A phase 3, randomized, active comparator, double-blind, multi center study to compare the efficacy, safety and tolerability of ITCA 650 to Sitagliptin as Add-on therapy to metformin in patients with Type 2 Diabetes
You may be able to take part if you:
* are between 18 and 80 years of age
* have been diagnosed with type 2 diabetes for more than 3 months.
Investigational product, examinations, and medical care relating to the study will be provided at no cost to you.